Breathe BioMedical Inc. (BRTH)

Breathe BioMedical was planning to go public, but the IPO was withdrawn on Oct 28, 2024.

IPO Price Range

$4.00 - $6.00

Shares Offered

2,625,000

Deal Size

$13.13M

Breathe BioMedical Financials Overview

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Income	-11.35	-9.17	-5.4	-5.05
Net Income	-10.54	-8.36	-4.46	-3.97

Fiscal Year	Current	FY 2023	FY 2022	FY 2021
Period Ending	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	2.53	1.66	0.57	0
Total Debt	3.31	1.93	1.23	-
Net Cash (Debt)	-0.78	-0.27	-0.66	0
Net Cash Growth	-	-	-	-

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-6.17	-5.09	-2.93	-2.75
Free Cash Flow	-6.98	-5.22	-3.53	-3.5
Free Cash Flow Growth	-	-	-	-